All In MedTech

Device Trial Radar · NCT04325464

A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic

Open-label, 9-week Treatment, De-centralized Trial to Collect Real World Evidence for a Digital Therapeutic (DT) Delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) for Participants With Chronic Insomnia

Last checked: Nov 20, 2026Latest source record: Feb 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

1,590

Actual

Start

Feb 18, 2020

Primary completion

Oct 21, 2022

Study completion Oct 31, 2024

Sponsor

Lead sponsor
Pear Therapeutics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 27, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to collect data in a real-world environment, for a digital therapeutic that delivers CBT-I through a decentralized clinical trial, open to participants with chronic insomnia.

Conditions

  • Chronic Insomnia

Interventions

  • PEAR-003ADevice

    PEAR-003A delivers CBT-I through a decentralized clinical trial open to participants with chronic insomnia

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Insomnia Severity Index (ISI)Time frame: From Baseline to Day 63 (End of Treatment) and Days 243, 428, 610, 793 (Follow-up)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pear Therapeutics, Inc.

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.